 Sherry Courtney
Concepts (187)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Infant, Premature | 24 | 2026 | 331 | 3.220 |
Why?
| | Noninvasive Ventilation | 5 | 2024 | 21 | 2.590 |
Why?
| | Respiratory Distress Syndrome, Newborn | 12 | 2022 | 45 | 2.190 |
Why?
| | Continuous Positive Airway Pressure | 10 | 2023 | 65 | 1.930 |
Why?
| | Work of Breathing | 6 | 2020 | 20 | 1.920 |
Why?
| | Tidal Volume | 11 | 2024 | 61 | 1.860 |
Why?
| | Infant, Newborn | 47 | 2026 | 2913 | 1.770 |
Why?
| | Respiration, Artificial | 10 | 2024 | 293 | 1.660 |
Why?
| | High-Frequency Ventilation | 6 | 2024 | 23 | 1.570 |
Why?
| | Intermittent Positive-Pressure Ventilation | 3 | 2024 | 19 | 1.450 |
Why?
| | Interactive Ventilatory Support | 3 | 2024 | 8 | 1.420 |
Why?
| | Infant, Premature, Diseases | 8 | 2020 | 97 | 1.130 |
Why?
| | Respiratory Insufficiency | 4 | 2021 | 119 | 1.080 |
Why?
| | Hypoxia-Ischemia, Brain | 3 | 2024 | 63 | 1.040 |
Why?
| | Ventilator-Induced Lung Injury | 2 | 2017 | 22 | 1.000 |
Why?
| | Bronchopulmonary Dysplasia | 10 | 2023 | 64 | 1.000 |
Why?
| | Hypothermia, Induced | 3 | 2024 | 46 | 0.920 |
Why?
| | Acute Kidney Injury | 3 | 2024 | 399 | 0.790 |
Why?
| | Intensive Care, Neonatal | 2 | 2019 | 23 | 0.630 |
Why?
| | Infant, Very Low Birth Weight | 8 | 2015 | 58 | 0.600 |
Why?
| | Blood Gas Monitoring, Transcutaneous | 1 | 2018 | 7 | 0.560 |
Why?
| | Lung Injury | 1 | 2018 | 25 | 0.560 |
Why?
| | Electrodes | 1 | 2018 | 35 | 0.560 |
Why?
| | Dermatitis | 1 | 2018 | 36 | 0.550 |
Why?
| | Ventilators, Mechanical | 2 | 2021 | 43 | 0.530 |
Why?
| | Temperature | 1 | 2018 | 165 | 0.520 |
Why?
| | Humans | 50 | 2026 | 53230 | 0.520 |
Why?
| | Mycoses | 1 | 2018 | 152 | 0.520 |
Why?
| | Respiratory Therapy | 1 | 2016 | 36 | 0.470 |
Why?
| | Pulmonary Surfactants | 4 | 2017 | 17 | 0.470 |
Why?
| | Infant | 14 | 2024 | 3805 | 0.460 |
Why?
| | Respiratory Mechanics | 6 | 2011 | 40 | 0.460 |
Why?
| | High-Frequency Jet Ventilation | 2 | 2006 | 6 | 0.450 |
Why?
| | Male | 27 | 2026 | 27435 | 0.450 |
Why?
| | Gestational Age | 9 | 2024 | 394 | 0.420 |
Why?
| | Nitric Oxide | 5 | 2021 | 233 | 0.410 |
Why?
| | Swine | 4 | 2018 | 440 | 0.400 |
Why?
| | Cross-Over Studies | 3 | 2023 | 241 | 0.390 |
Why?
| | Intraabdominal Infections | 2 | 2021 | 7 | 0.340 |
Why?
| | Prospective Studies | 6 | 2024 | 2411 | 0.330 |
Why?
| | Plethysmography | 4 | 2019 | 43 | 0.320 |
Why?
| | Female | 24 | 2026 | 28782 | 0.320 |
Why?
| | Erythropoietin | 2 | 2020 | 51 | 0.310 |
Why?
| | Lung Compliance | 4 | 2016 | 9 | 0.260 |
Why?
| | Infant, Extremely Premature | 3 | 2024 | 33 | 0.250 |
Why?
| | Supine Position | 1 | 2006 | 26 | 0.250 |
Why?
| | Prone Position | 1 | 2006 | 29 | 0.250 |
Why?
| | Furosemide | 1 | 2026 | 13 | 0.240 |
Why?
| | Diuretics | 1 | 2026 | 27 | 0.240 |
Why?
| | Interleukin-18 | 2 | 2024 | 26 | 0.230 |
Why?
| | Respiration | 2 | 2020 | 94 | 0.220 |
Why?
| | Models, Biological | 3 | 2026 | 737 | 0.220 |
Why?
| | Anti-Bacterial Agents | 2 | 2021 | 830 | 0.220 |
Why?
| | Ventilator Weaning | 2 | 2021 | 21 | 0.220 |
Why?
| | Acute Lung Injury | 1 | 2024 | 30 | 0.210 |
Why?
| | Hernia, Inguinal | 1 | 2024 | 22 | 0.210 |
Why?
| | Ductus Arteriosus, Patent | 1 | 2024 | 40 | 0.210 |
Why?
| | Herniorrhaphy | 1 | 2024 | 33 | 0.210 |
Why?
| | Tracheobronchomalacia | 1 | 2023 | 10 | 0.200 |
Why?
| | Biological Clocks | 1 | 2002 | 16 | 0.190 |
Why?
| | Feasibility Studies | 1 | 2024 | 411 | 0.190 |
Why?
| | Infant, Low Birth Weight | 2 | 2020 | 77 | 0.180 |
Why?
| | Air Pressure | 3 | 2018 | 5 | 0.180 |
Why?
| | Cardiac Catheterization | 1 | 2024 | 229 | 0.180 |
Why?
| | Tissue Inhibitor of Metalloproteinase-2 | 1 | 2021 | 11 | 0.180 |
Why?
| | Insulin-Like Growth Factor Binding Proteins | 1 | 2021 | 27 | 0.180 |
Why?
| | Cystatin C | 1 | 2021 | 8 | 0.180 |
Why?
| | Animals | 5 | 2024 | 13526 | 0.170 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2022 | 150 | 0.170 |
Why?
| | Vasoconstrictor Agents | 1 | 2021 | 81 | 0.170 |
Why?
| | Patient Care Team | 1 | 2022 | 278 | 0.160 |
Why?
| | Metronidazole | 1 | 2020 | 32 | 0.160 |
Why?
| | Hypertension, Pulmonary | 1 | 2021 | 102 | 0.160 |
Why?
| | Treatment Outcome | 5 | 2024 | 5595 | 0.160 |
Why?
| | Apnea | 1 | 2020 | 16 | 0.160 |
Why?
| | Attitude of Health Personnel | 1 | 2003 | 371 | 0.160 |
Why?
| | Blood Transfusion | 1 | 2020 | 127 | 0.150 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2022 | 305 | 0.150 |
Why?
| | Lung | 3 | 2017 | 481 | 0.150 |
Why?
| | Partial Pressure | 1 | 2018 | 14 | 0.150 |
Why?
| | Administration, Inhalation | 5 | 2021 | 108 | 0.140 |
Why?
| | Time Factors | 3 | 2018 | 2991 | 0.140 |
Why?
| | Retrospective Studies | 5 | 2024 | 6819 | 0.140 |
Why?
| | Brain | 2 | 2024 | 1350 | 0.140 |
Why?
| | Carbon Dioxide | 1 | 2018 | 97 | 0.140 |
Why?
| | Random Allocation | 1 | 2018 | 284 | 0.140 |
Why?
| | Fatal Outcome | 1 | 2018 | 193 | 0.140 |
Why?
| | Informed Consent | 1 | 2018 | 94 | 0.130 |
Why?
| | Exhalation | 1 | 2016 | 20 | 0.130 |
Why?
| | Magnetic Resonance Imaging | 1 | 2024 | 1583 | 0.130 |
Why?
| | Infant, Extremely Low Birth Weight | 1 | 2017 | 29 | 0.130 |
Why?
| | Dose-Response Relationship, Drug | 4 | 2026 | 1367 | 0.130 |
Why?
| | Disease Models, Animal | 2 | 2024 | 1517 | 0.120 |
Why?
| | Patient Selection | 1 | 2018 | 273 | 0.120 |
Why?
| | Monitoring, Physiologic | 1 | 2016 | 122 | 0.120 |
Why?
| | Oxygen | 1 | 2018 | 338 | 0.120 |
Why?
| | Decision Making | 1 | 2018 | 278 | 0.120 |
Why?
| | Age Factors | 4 | 2024 | 1136 | 0.120 |
Why?
| | Double-Blind Method | 4 | 2020 | 729 | 0.110 |
Why?
| | Parents | 1 | 2018 | 341 | 0.110 |
Why?
| | Cyclic GMP | 1 | 2014 | 16 | 0.110 |
Why?
| | Pilot Projects | 2 | 2013 | 726 | 0.100 |
Why?
| | Lung Diseases | 2 | 2006 | 84 | 0.100 |
Why?
| | Case-Control Studies | 1 | 2016 | 1212 | 0.100 |
Why?
| | Lung Volume Measurements | 2 | 2003 | 8 | 0.100 |
Why?
| | Reproducibility of Results | 1 | 2016 | 1219 | 0.100 |
Why?
| | Pulmonary Surfactant-Associated Protein B | 1 | 2012 | 4 | 0.100 |
Why?
| | Models, Theoretical | 1 | 2013 | 180 | 0.100 |
Why?
| | United States | 5 | 2024 | 5409 | 0.100 |
Why?
| | Equipment Safety | 1 | 2009 | 11 | 0.080 |
Why?
| | Positive-Pressure Respiration | 1 | 2010 | 63 | 0.080 |
Why?
| | Birth Weight | 2 | 2013 | 119 | 0.070 |
Why?
| | Respiratory Function Tests | 2 | 2011 | 89 | 0.070 |
Why?
| | Respiratory System | 1 | 2008 | 28 | 0.070 |
Why?
| | Equipment Failure | 1 | 2008 | 64 | 0.070 |
Why?
| | Pressure | 1 | 2008 | 102 | 0.070 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2024 | 630 | 0.070 |
Why?
| | Adaptation, Physiological | 1 | 2008 | 109 | 0.070 |
Why?
| | Cohort Studies | 2 | 2022 | 1557 | 0.060 |
Why?
| | Body Weight | 1 | 2008 | 524 | 0.060 |
Why?
| | Nephrolithiasis | 1 | 2026 | 3 | 0.060 |
Why?
| | Nephrocalcinosis | 1 | 2026 | 7 | 0.060 |
Why?
| | Monte Carlo Method | 1 | 2026 | 89 | 0.060 |
Why?
| | Equipment Design | 1 | 2006 | 290 | 0.060 |
Why?
| | Pregnancy | 2 | 2023 | 2608 | 0.060 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2024 | 21 | 0.050 |
Why?
| | Diaphragm | 1 | 2024 | 32 | 0.050 |
Why?
| | Clinical Trials, Phase III as Topic | 1 | 2024 | 48 | 0.050 |
Why?
| | Septal Occluder Device | 1 | 2024 | 36 | 0.050 |
Why?
| | Bethanechol | 1 | 2023 | 4 | 0.050 |
Why?
| | Multicenter Studies as Topic | 1 | 2024 | 114 | 0.050 |
Why?
| | Airway Extubation | 1 | 2024 | 30 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2024 | 120 | 0.050 |
Why?
| | Survival Rate | 2 | 2017 | 949 | 0.050 |
Why?
| | Rabbits | 1 | 2024 | 372 | 0.050 |
Why?
| | Thoracic Wall | 1 | 2003 | 8 | 0.050 |
Why?
| | Follow-Up Studies | 2 | 2020 | 2318 | 0.050 |
Why?
| | Reference Values | 1 | 2003 | 311 | 0.050 |
Why?
| | Nonlinear Dynamics | 1 | 2002 | 18 | 0.050 |
Why?
| | Pulmonary Wedge Pressure | 1 | 2002 | 18 | 0.050 |
Why?
| | Multivariate Analysis | 1 | 2024 | 598 | 0.050 |
Why?
| | Oximetry | 1 | 2023 | 65 | 0.050 |
Why?
| | Intracranial Hemorrhages | 1 | 2002 | 44 | 0.050 |
Why?
| | Regression Analysis | 2 | 2014 | 391 | 0.050 |
Why?
| | Models, Animal | 1 | 2002 | 233 | 0.040 |
Why?
| | Drug Administration Schedule | 2 | 2017 | 370 | 0.040 |
Why?
| | Length of Stay | 2 | 2021 | 684 | 0.040 |
Why?
| | Patient Discharge | 1 | 2024 | 325 | 0.040 |
Why?
| | Proportional Hazards Models | 1 | 2002 | 445 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2003 | 867 | 0.040 |
Why?
| | Ambulatory Care | 1 | 2022 | 239 | 0.040 |
Why?
| | Hemorrhage | 1 | 2002 | 226 | 0.040 |
Why?
| | Drug Therapy, Combination | 1 | 2020 | 405 | 0.040 |
Why?
| | Airway Resistance | 2 | 2011 | 16 | 0.030 |
Why?
| | Prevalence | 1 | 2021 | 1034 | 0.030 |
Why?
| | Kidney | 1 | 2023 | 715 | 0.030 |
Why?
| | Registries | 1 | 2021 | 652 | 0.030 |
Why?
| | Ultrasonography | 1 | 2020 | 426 | 0.030 |
Why?
| | Berlin | 1 | 2017 | 2 | 0.030 |
Why?
| | Rwanda | 1 | 2017 | 15 | 0.030 |
Why?
| | Chi-Square Distribution | 1 | 2018 | 291 | 0.030 |
Why?
| | Terminology as Topic | 1 | 2017 | 72 | 0.030 |
Why?
| | Confidence Intervals | 1 | 2017 | 158 | 0.030 |
Why?
| | Intensive Care Units, Pediatric | 1 | 2017 | 158 | 0.030 |
Why?
| | Consensus | 1 | 2017 | 206 | 0.030 |
Why?
| | Algorithms | 2 | 2011 | 667 | 0.030 |
Why?
| | Diuresis | 1 | 2013 | 13 | 0.030 |
Why?
| | Creatinine | 1 | 2014 | 158 | 0.030 |
Why?
| | Calibration | 1 | 2013 | 58 | 0.030 |
Why?
| | Early Diagnosis | 1 | 2013 | 84 | 0.030 |
Why?
| | Area Under Curve | 1 | 2013 | 185 | 0.030 |
Why?
| | ROC Curve | 1 | 2013 | 246 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 1723 | 0.020 |
Why?
| | Risk Assessment | 1 | 2017 | 1368 | 0.020 |
Why?
| | Models, Anatomic | 1 | 2011 | 40 | 0.020 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2011 | 61 | 0.020 |
Why?
| | Weight Loss | 1 | 2013 | 257 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2013 | 934 | 0.020 |
Why?
| | Child, Preschool | 1 | 2020 | 4162 | 0.020 |
Why?
| | Intubation, Intratracheal | 1 | 2011 | 116 | 0.020 |
Why?
| | Child | 1 | 2022 | 7379 | 0.020 |
Why?
| | Entropy | 1 | 2008 | 7 | 0.020 |
Why?
| | Masks | 1 | 2007 | 27 | 0.020 |
Why?
| | Survival Analysis | 1 | 2006 | 659 | 0.010 |
Why?
| | Adult | 1 | 2020 | 14534 | 0.010 |
Why?
| | Radiography | 1 | 2005 | 476 | 0.010 |
Why?
| | Esophagus | 1 | 2003 | 83 | 0.010 |
Why?
|
|
Courtney's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|